Provided by Tiger Trade Technology Pte. Ltd.

Sutro Biopharma Inc

20.49
-0.5500-2.61%
Post-market: 20.490.00000.00%16:20 EDT
Volume:275.11K
Turnover:5.59M
Market Cap:339.46M
PE:-1.18
High:21.51
Open:21.49
Low:19.55
Close:21.04
52wk High:43.85
52wk Low:7.15
Shares:16.57M
Float Shares:10.77M
Volume Ratio:1.01
T/O Rate:2.56%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-17.3700
EPS(LYR):-22.4900
ROE:-1810.01%
ROA:-36.08%
PB:-3.29
PE(LYR):-0.91

Loading ...

Sutro Biopharma Is Maintained at Market Outperform by Citizens

Dow Jones
·
Apr 23

Sutro Biopharma price target raised to $41 from $35 at Citizens

TIPRANKS
·
Apr 23

Sutro Biopharma presents preclinical data across its pipeline of ADCs

TIPRANKS
·
Apr 20

Sutro Biopharma says Phase 1 STRO-004 trial initial results due mid-2026

Reuters
·
Apr 20

Sutro Biopharma Presents Promising Preclinical Data Across its Pipeline of Next-Generation Single and Dual-Payload ADC Programs at AACR 2026

GlobeNewswire
·
Apr 20

Sutro Biopharma Is Maintained at Market Outperform by Citizens

Dow Jones
·
Apr 17

Sutro Biopharma price target raised to $35 from $23 at Citizens

TIPRANKS
·
Apr 17

Sutro Biopharma Initiated at Outperform by Leerink Partners

Dow Jones
·
Apr 07

Leerink Partners Initiates Sutro Biopharma at Outperform With $38 Price Target

MT Newswires Live
·
Apr 07

Sutro Biopharma initiated with an Outperform at Leerink

TIPRANKS
·
Apr 07

Sutro Biopharma Inc : Leerink Partners Initiates Coverage With Outperform Rating; Target Price $38

THOMSON REUTERS
·
Apr 07

BRIEF-Sutro Biopharma Enters Sales Agreement, May Offer & Sell Shares Of Common Stock Of Up To $100 Million - SEC Filing

Reuters
·
Apr 02

Sutro Biopharma Faces Rising Operational Risks Amid Escalating U.S.-China Trade Tensions

TIPRANKS
·
Mar 25

Sutro Biopharma Inc : Piper Sandler Raises Target Price to $29 From $20

THOMSON REUTERS
·
Mar 24

Sutro Biopharma Inc. : Wells Fargo Raises to Overweight From Equal Weight

THOMSON REUTERS
·
Mar 24

Wedbush Raises Price Target on Sutro Biopharma to $22 From $10, Keeps Neutral Rating

MT Newswires Live
·
Mar 24

Sutro Biopharma Raised to Buy From Neutral by HC Wainwright & Co.

Dow Jones
·
Mar 24

Sutro Biopharma upgraded to Buy from Neutral at H.C. Wainwright

TIPRANKS
·
Mar 24

U.S. RESEARCH ROUNDUP-Apogee Therapeutics, Insmed, Sunoco

Reuters
·
Mar 24

Sutro Biopharma upgraded to Overweight from Equal Weight at Wells Fargo

TIPRANKS
·
Mar 24